Highlights Torii Pharmaceutical Co., Ltd.

Equities

4551

JP3635800000

Delayed Japan Exchange Other stock markets 22:30:00 2024-05-09 EDT			5-day change	1st Jan Change
4,080 ^JPY	+1.12%		+3.03%	+14.77%

02-13	LIM Advisors Partially Withdraws Shareholder Proposal	CI
02-09	Torii Pharmaceuticals Opposes Shareholder Proposal	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	12-27	FA
Torii Pharmaceutical Co., Ltd. Announces Positive Top-Line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan	12-15	CI
ALK Abello Adds Grass Pollen Allergy Drug to Torii License Deal in Japan	12-12	MT
ALK-Abelló A/S Expands Partnership with Torii Pharmaceutical Co., Ltd. in Japan	12-12	CI
Ex-dividend day for interim dividend	23-06-28	FA
Ex-dividend day for final dividend	22-12-28	FA
Torii Pharmaceutical Co., Ltd. Announces Start of Phase 3 Trial of VP-102 for the Treatment of Molluscum Contagiosum	22-08-01	CI
Ex-dividend day for interim dividend	22-06-28	FA
Ex-dividend day for final dividend	21-12-28	FA
Ex-dividend day for interim dividend	21-06-28	FA
Torii Pharmaceutical Co., Ltd. Plans to Launch of CORECTIM Ointment 0.25% in Japan	21-05-26	CI
Akebia Therapeutics : Obtains Approval For Additional Indication of Riona Tablets in Japan	21-03-24	MT
Japan Tobacco : Torii Pharmaceutical's Atopic Dermatitis Ointment Receives Manufacturing, Marketing Approval; Shares Fall 3%	21-03-24	MT
Verrica Pharmaceuticals : Torii Strike Exclusive Licensing Deal To Develop, Commercialize VP-102 For Molluscum, Common Warts in Japan	21-03-17	MT
Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercialize VP-102 For Molluscum and Common Warts in Japan	21-03-17	CI
Ex-dividend day for final dividend	20-12-28	FA
Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. Receives Manufacturing and Marketing Approval of Enaroy Tablets 2 Mg4 Mg	20-09-25	CI
Iwaki Seiyaku Co., Ltd. completed the acquisition of Sakura Plant from Torii Pharmaceutical Co., Ltd..	20-06-30	CI
Ex-dividend day for interim dividend	20-06-28	FA
Torii and ASKA Enter into Co-Promotion Agreement Concerning Additional Indication of Iron Deficiency Anemia for Riona	20-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Torii Pharmaceutical Co., Ltd.

Equities

4551

JP3635800000

Highlights

Filters